NCT01072877View on ClinicalTrials.gov

Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence

PHASE3CompletedINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

November 30, 2012

Conditions
Varicose Veins
Interventions
DRUG

Polidocanol injectable foam (PEM)

Injection of Polidocanol injectable foam

DRUG

Placebo Vehicle

Placebo vehicle

Trial Locations (20)

10016

New York

10530

Hartsdale

Stony Brook

14120

North Tonawanda

20007

Washington D.C.

27157

Winston-Salem

27705

Durham

28207

Charlotte

33180

Aventura

34209

Bradenton

37040

Clarksville

43606

Toledo

48109

Ann Arbor

49009

Kalamazoo

60181

Oakbrook Terrace

92653

Laguna Hills

97701

Bend

98034

Kirkland

99204

Spokane

Unknown

San Diego

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY